These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 38351947)

  • 1. Malignant pleural disease.
    Piggott LM; Hayes C; Greene J; Fitzgerald DB
    Breathe (Sheff); 2023 Dec; 19(4):230145. PubMed ID: 38351947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
    Qureshi M; Thapa B; Muruganandan S
    Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Septated Malignant Pleural Effusions.
    Banka R; Terrington D; Mishra EK
    Curr Pulmonol Rep; 2018; 7(1):1-5. PubMed ID: 29568725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
    Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
    Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.
    Bibby AC; Halford P; De Fonseka D; Morley AJ; Smith S; Maskell NA
    Ann Am Thorac Soc; 2019 Oct; 16(10):1273-1279. PubMed ID: 31189069
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
    Augeri S; Capano S; Morone S; Fissolo G; Giacomino A; Peola S; Drace Z; Rapa I; Novello S; Volante M; Righi L; Ferrero E; Ortolan E; Funaro A
    Oncotarget; 2018 Apr; 9(32):22785-22801. PubMed ID: 29854315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of malignant pleural effusions].
    Loddenkemper R
    Pneumologie; 2005 Feb; 59(2):120-35. PubMed ID: 15724226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma.
    Zallocco L; Silvestri R; Ciregia F; Bonotti A; Marino R; Foddis R; Lucacchini A; Giusti L; Mazzoni MR
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracoscopic management of malignant pleural effusions.
    Colt HG
    Clin Chest Med; 1995 Sep; 16(3):505-18. PubMed ID: 8521705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the diagnosis and management of malignant pleural effusions.
    Bashour SI; Mankidy BJ; Lazarus DR
    Respir Med; 2022 May; 196():106802. PubMed ID: 35287006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
    JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
    DeLong P; Carroll RG; Henry AC; Tanaka T; Ahmad S; Leibowitz MS; Sterman DH; June CH; Albelda SM; Vonderheide RH
    Cancer Biol Ther; 2005 Mar; 4(3):342-6. PubMed ID: 15846066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.
    Creaney J; Dick IM; Robinson BW
    Curr Opin Pulm Med; 2015 Jul; 21(4):352-6. PubMed ID: 26016578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex Soluble Biomarker Analysis from Pleural Effusion.
    Javadi J; Dobra K; Hjerpe A
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32731396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pleural mesothelioma--case report].
    Mestrović IP; Dragicević M; Mosler D; Mestrović T; Mosler EL; Kozmar D; Kranjcević S; Pocanić D; Cavrić G; Skorić KN; Letilović T; Jerkić H; Zeljko H; Kardum-Skelin I
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():213-6. PubMed ID: 23126055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].
    Biesterfeld S; Schramm M; Schad A; Pomjanski N
    Pneumologie; 2014 Apr; 68(4):270-6. PubMed ID: 24615665
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.